Hong Kong Exchanges & Clearing Ltd Stock News

Hong Kong Exchanges and Clearing (HKEX) posted record annual profit for a fourth consecutive year on the back of higher trading and clearing fees as turnover increased.

Hong Kong Exchanges and Clearing (HKEX), which runs the third largest stock market in Asia, posted record annual profit for a fourth consecutive year as turnover soared.The exchange operator posted a 9 per cent increase in net profit to HK$12.54 billion (US$1.6 billion) for 2021, or HK$9.91 per share, according to a stock exchange filing on Thursday.The profit was lower than the consensus forecast of a 14 per cent increase to HK$13.14 billion, according to analysts polled by Bloomberg.“HKEX had…

Hong Kong stocks fell to a two-week low amid concerns new regulations will hurt the outlook for corporate earnings as companies including HSBC, Alibaba Group Holding and NetEase prepare to issue their report cards.The Hang Seng Index retreated 0.6 per cent to 24,175.46 at 10.45am local time. The Tech Index declined 1.4 per cent, while the Shanghai Composite Index lost 0.4 per cent.Alibaba tumbled 2.8 per cent while Tencent slipped 2.7 per cent. Bourse operator Hong Kong Exchanges & Clearing

All currency figures stated in this report are in US Dollars unless stated otherwise. The consolidated financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS"). SHANGHAI , Feb. 10, 2022 /PRNewswire/ -- Semiconductor Manufacturing International Corporation (SEHK: 00981; SSE STAR MARKET: 688981) ("SMIC", the "Company" or "we"), one of the leading semiconductor foundries in the world, today announced its consolidated results of operations for the three months ended December 31, 2021 . 20 21 Fourth Quarter Highlights Revenue was $1,580.1 million in 4Q21, an increase of 11.6% QoQ from $1,415.3 million in 3Q21, and 61.1% YoY from $981.1 million in 4Q20. Gross profit was $552.8 million in 4Q21, an increase of 18.2% QoQ from $467.9 million in 3Q21, and 212.7% YoY from $176.8 million in 4Q20. Gross margin was 35.0% in 4Q21, compared to 33.1% in 3Q21 and 18.0% in 4Q20. First Quarter 2022 Guidance The following statements are forward looking statements based on current expectations and involved risks and uncertainties.

HKEx Finalizes New Rules on Listings for Overseas Issuers - Following a consultation process conducted earlier in 2021, the Stock Exchange of Hong Kong Limited (HKEx) has announced amended listing rules for overseas companies undertaking dual-primary or secondary listings in Hong Kong. By: Skadden, Arps, Slate, Meagher & Flom LLP

Hong Kong Exchanges and Clearing Limited (HKEX) announces the listings of three ETFs linked to the MSCI China A 50 Connect Index. The post First ETFs tracking MSCI China A 50 launched in Hong Kong appeared first on Fund Selector Asia .

HONG KONG, Dec. 13, 2021 /PRNewswire/ -- Hong Kong Exchanges and Clearing Limited (HKEX) is today (Monday) pleased to welcome the listings of the first ETFs to track the MSCI China A50 Connect Ind

The Hong Kong Exchanges and Clearing is set to face even more headwinds, in addition to a Chinese regulatory crackdown, with the latest blacklisting of artificial intelligence firm SenseTime for its alleged enablement of human rights abuses against Muslim Uighurs in Xinjiang. Last week, the U.S. Treasury placed SenseTime on the blacklist for human rights abuse against Xinjiangs Muslim Uighurs which derailed the facial recognition technology firms listing plans in Hong Kong. After a «Financial Times» report of the expected blacklisting on Thursday, SenseTime did not proceed with a planned pricing of its shares in Hong Kong on Friday. In addition to denying the claims, calling them «unfounded» and reflective of a «fundamental misperception» of SenseTime, the firm will now delay its Hong Kong IPO which was scheduled for December 17, according to multiple media reports. SenseTime IPO SenseTimes original plan was to raise as much as $767 million as it sought a valuation of up to $17 billion.

Hong Kong Exchanges & Clearing is reportedly planning to open a New York office as part of its broader plans for internationalization. HKEX plans to establish a New York office to market its offerings in the U.S., according to a «Bloomberg» report citing unnamed sources, with a headcount for around five staff. Officials at the bourse dont expect the «modest office opening» to meet any political opposition, the report added. Foreign Expansion The new office plans occur in the midst of HKEX ongoing ambitions to expand abroad two years after a failed acquisition of the London Stock Exchange (LSE). LSE cited the Hong Kong bourse''s «unusual» structure of allowing a non-majority shareholder to appoint the chairman and half of the board as the reason to reject a $36.6 billion bid in 2019. If successful, New York would be the HKEX first presence in the U.S. in addition to offices in Shanghai, Beijing, Singapore and London, where it owns the London Metal Exchange.

IPO consultant Richard Lum, who had been accused of paying bribes to Yeoh, was also found not guilty. Yeoh''s role at Hong Kong Exchanges and Clearing (HKEX) was to make sure applications were compliant with listing rules and endorse recommendations to the bourses listing committees which have the final say on a listing candidate''s eligibility.

IPO consultant Richard Lum, who had been accused of paying bribes to Yeoh, was also found not guilty. Yeoh''s role at Hong Kong Exchanges and Clearing was to make sure applications were compliant with listing rules and endorse recommendations to the bourses listing committees which have the final say on a listing candidate''s eligibility.

BEIJING , Dec. 2, 2021 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (Nasdaq: WB), a leading social media platform in China , today announced the pricing of the global offering (the "Global Offering") of an aggregate of 11,000,000 Class A ordinary shares of the Company. Weibo is offering 5,500,000 Class A ordinary shares of the Company (the "New Shares") and Sina Corporation (the "Selling Shareholder") is offering 5,500,000 Class A ordinary shares of the Company, which are to be converted from the same number of Class B ordinary shares of the Company prior to the listing of Weibo''s Class A ordinary shares on the Hong Kong Stock Exchange as defined below (the "Sale Shares," and together with New Shares, the "Offer Shares"). The Global Offering comprises of a Hong Kong public offering (the "Hong Kong Public Offering") and an international offering (the "International Offering"). The final offer price for both the International Offering and the Hong Kong Public Offering (the "Offer Price") has been set as HK$272.80 per Offer Share.

Hong Kong Exchanges and Clearing Limited (OTCMKTS:HKXCY) was the recipient of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 33,100 shares, an increase of 329.9% from the October 31st total of 7,700 shares. Based on an average daily trading volume, of 65,100 shares, []

On 6 July 2021, the Hong Kong Exchanges and Clearing Limited (the HKEx) published its conclusions in response to its concept paper on the introduction of a new IPO settlement platform Fast Interface for New Issuance (FINI). The aim of this innovation is to provide an interactive digital platform for market participants, to reduce market risk associated with Hong Kong dollar liquidity issues and to bring Hong Kong in line with other leading international equity listing venues in terms of By: Dechert LLP

SAN FRANCISCO and SUZHOU, China , Nov. 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, announces the Company''s stock is included in the Hang Seng China Enterprises Index (HSCEI) according to the Hang Seng Indexes Company''s latest results of review. The inclusion will take effect on December 6, 2021 . The HSCEI is one of the most influential indexes in the Hong Kong and global stock markets, as constituted by 50 leading China enterprises listed on the Hong Kong Stock Exchanges with outstanding market cap and trading volume. Innovent is the first and only biopharmaceutical company listed under Chapter 18A of the Hong Kong Stock Exchanges to be included in the HSCEI, and the inclusion could indicate potential additional capital inflow from passive index funds. Mr. Ronald Ede , Executive Director and CFO of Innovent, stated, "We are excited that our stock is included into the HSCEI, following the successful inclusion in the Hang Seng Composite Index and the Stock Connect last year.